Glenmark Pharma launches Empagliflozin and its fixed-drug combinations in India
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Subscribe To Our Newsletter & Stay Updated